Orix (IX) Net Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Orix (IX) Net Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 43.64 Bn | 43.64 Bn | 4.68 Bn | 1,767.00 |
| 2 | Royalty Pharma | 26.15 Bn | 25.32 Bn | - | -392.00 |
| 3 | Royal Gold | 21.54 Bn | 21.36 Bn | 390.45 Mn | -1,046.00 |
| 4 | OR Royalties | 6.72 Bn | 6.64 Bn | 82.22 Mn | 1,233.00 |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | -27.00 |
| 6 | Atlanticus Holdings | 1.41 Bn | 857.38 Mn | 686.46 Mn | -82.00 |
| 7 | Jefferson Capital | 1.18 Bn | 1.15 Bn | - | -794.00 |
| 8 | Upbound | 1.06 Bn | 953.54 Mn | 594.84 Mn | 52.00 |
| 9 | Lufax Holding | 1.05 Bn | -1.58 Bn | - | -144.00 |
| 10 | Burford Capital | 962.26 Mn | 962.26 Mn | - | -4,641.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,767.00 |
| Mar 31, 2026 | -484.00 |
| Dec 31, 2025 | -101.00 |
| Sep 30, 2025 | 880.00 |
| Jun 30, 2025 | 211.00 |
| Mar 31, 2025 | -539.00 |
| Dec 31, 2024 | 162.00 |
| Sep 30, 2024 | 170.00 |
| Jun 30, 2024 | 294.00 |
| Mar 31, 2024 | 475.00 |
| Dec 31, 2023 | -79.00 |
| Sep 30, 2023 | 100.00 |
| Jun 30, 2023 | -11.00 |
| Mar 31, 2023 | -484.00 |
| Dec 31, 2022 | 390.00 |
| Sep 30, 2022 | -433.00 |
| Jun 30, 2022 | -130.00 |
| Mar 31, 2022 | 854.00 |
| Dec 31, 2021 | 203.00 |
| Sep 30, 2021 | 487.00 |